Showing results (2031-2040 of 14,098) with videos related to
Sort By:
Pageof 1,410
Gynecologic Oncology|December 14, 2019
Effect of patient education on palliative care knowledge and acceptability of outpatient palliative care services among gynecologic oncology patients: A randomized controlled trialA Graul, A Haggerty, C Stickley, et al.Gynecologic Oncology|January 19, 2020
Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: A survival analysisV Ghirardi, M C Moruzzi, N Bizzarri, et al.Gynecologic Oncology|January 20, 2020
Diagnosis and management of growing teratoma syndrome after ovarian immature teratoma: A single center experienceDan Wang, Shan Zhu, Congwei Jia, et al.Gynecologic Oncology|January 20, 2020
Diagnosis-shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based studyKoji Matsuo, Hiroko Machida, Brendan H Grubbs, et al.Gynecologic Oncology|January 20, 2020
Hormone receptor expression and outcomes in low-grade serous ovarian carcinomaMarta Llaurado Fernandez, Amy Dawson, Hannah Kim, et al.Gynecologic Oncology|November 24, 2019
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancerMarina Stasenko, Irina Tunnage, Charles W Ashley, et al.Gynecologic Oncology|November 25, 2019
Off-study utilization of experimental therapies: Analysis of GOG249-eligible cohorts using real world dataParth A Chodavadia, Corbin D Jacobs, Frances Wang, et al.Gynecologic Oncology|November 25, 2019
Socioeconomic deprivation and survival in endometrial cancer: The effect of BMIH Donkers, R Bekkers, L Massuger, et al.Gynecologic Oncology|January 28, 2020
Association between pelvic inflammatory disease, infertility, ectopic pregnancy and the development of ovarian serous borderline tumor, mucinous borderline tumor and low-grade serous carcinomaL M Stewart, C J R Stewart, K Spilsbury, et al.Gynecologic Oncology|January 28, 2020
The Moore Criteria: Applicability in a diverse, non-trial, recurrent cervical cancer populationScott E Jordan, Matthew Schlumbrecht, Sophia George, et al.Pageof 1,410